These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 363664)

  • 21. [Lung defenses against bacterial infection. From analysis to synthesis (author's transl)].
    Voisin C
    Bull Eur Physiopathol Respir; 1977; 13(1):3-7. PubMed ID: 843647
    [No Abstract]   [Full Text] [Related]  

  • 22. The concentrations of IgA and free secretory piece in the nasal secretions of patients with recurrent respiratory infections.
    Stanley PJ; Cole PJ
    Clin Exp Immunol; 1985 Jan; 59(1):197-202. PubMed ID: 3918818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine].
    Henocq A; Moreau C; Mallet E; Sauger F; de Menibus CH
    Ann Otolaryngol Chir Cervicofac; 1985; 102(5):373-5. PubMed ID: 4037622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide].
    Maeda M; Ozaki T; Yasuoka S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):135-42. PubMed ID: 2355674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of some immunological factors in the development of recurring respiratory diseases in children (author's transl)].
    Sónak R; Randusková A; Sulko M
    Bratisl Lek Listy; 1975 May; 63(5):588-96. PubMed ID: 1125795
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological factors in nasal mucosa of patients with leprosy--immunoperoxidase study.
    Mehta L; Ridley MJ; Antia NH
    Indian J Lepr; 1985; 57(2):311-7. PubMed ID: 3908577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surface defense mechanisms of the nasal mucosa].
    Makowska W; Zawisza E
    Pol Tyg Lek; 1978 Aug; 33(35):1391-3. PubMed ID: 30972
    [No Abstract]   [Full Text] [Related]  

  • 28. [Histological and immunological aspects of allergic and non allergic nasal mucosae. A study of 64 biopsies (author's transl)].
    Appaix A; Besson J; Casanova P; Garbe L; Rondini JM; Berro C
    Ann Otolaryngol Chir Cervicofac; 1978; 95(10-11):637-52. PubMed ID: 373571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanisms of lesions of nasal mucosa microcirculation in allergic rhinitis].
    Aref'eva NA; Bikhbaeva AI; Vagapova VSh; Saltykov BB
    Vestn Otorinolaringol; 1992; (1):8-11. PubMed ID: 1589951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory tract immune response to microbial pathogens.
    Wilkie BN
    J Am Vet Med Assoc; 1982 Nov; 181(10):1074-9. PubMed ID: 6294027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secretory IgA and the antibacterial defenses of the respiratory tract (author's transl)].
    Michel FB; Bousquet J; Dussourd d'Hinterland L
    Bull Eur Physiopathol Respir; 1977; 13(1):27-46. PubMed ID: 402966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indicators of nonspecific resistance and peripheral blood in viral and mycoplasma respiratory tract infections].
    Chebotkevich VN; Shamanova MG; Geĭker VI
    Ter Arkh; 1980; 52(11):29-32. PubMed ID: 7466650
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the defense mechanisms in the respiratory system. Report II. Studies on lysozyme as a defense factor against infection].
    Kado M
    Bull Chest Dis Res Inst Kyoto Univ; 1980 Mar; 13(1-2):32-43. PubMed ID: 6927788
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiologic factors and isotype-specific antibody responses in serum and mucosal secretions of dairy calves with bovine coronavirus respiratory tract and enteric tract infections.
    Heckert RA; Saif LJ; Myers GW; Agnes AG
    Am J Vet Res; 1991 Jun; 52(6):845-51. PubMed ID: 1652904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enhancement of MIF activity by inhibition of macrophage associated esterases.
    Remold HG
    J Immunol; 1974 Apr; 112(4):1571-7. PubMed ID: 4592606
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lung defenses against bacterial infections and their alterations (author's transl)].
    Voisin C; Tonnel AB; Aerts C
    Schweiz Rundsch Med Prax; 1979 Dec; 68(52):1727-31. PubMed ID: 548973
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bronchopulmonary infections and deficient function of the alveolar phagocyte. I. The alveolar macrophage: means of its study and role in the defense of the respiratory tract against infection].
    Voisin C; Aerts C; Tonnel AB; Petitprez A
    Rev Tuberc Pneumol (Paris); 1972; 36(3):357-76. PubMed ID: 5080966
    [No Abstract]   [Full Text] [Related]  

  • 38. [The value of a micro-complement fixation test in the serology of respiratory virus infections (author's transl)].
    Freymuth F; Morel C
    Ann Microbiol (Paris); 1974 Apr; 125A(3):387-93. PubMed ID: 4417373
    [No Abstract]   [Full Text] [Related]  

  • 39. [Natural resistence of human skin against bacterial infection. The role of lysozyme in the defense system (author's transl)].
    Kavanová K; Krs V; Konopík J; Chaloupecký V
    Cesk Dermatol; 1977 Jun; 52(3):155-60. PubMed ID: 902333
    [No Abstract]   [Full Text] [Related]  

  • 40. A review of respiratory virology and the spread of virulent and possibly antigenic viruses via air conditioning systems. I.
    Zeterberg JM
    Ann Allergy; 1973 May; 31(5):228-34. PubMed ID: 4739701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.